TY - JOUR KW - Buprenorphine/therapeutic use KW - COVID-19/epidemiology KW - Cross-Sectional Studies KW - Drug Overdose/epidemiology/ethnology/mortality KW - Emergency Medical Services/statistics & numerical data KW - Health Services Accessibility/organization & administration KW - Humans KW - Methadone/therapeutic use KW - Narcotic Antagonists/therapeutic use KW - Opiate Substitution Treatment KW - Opioid-Related Disorders/drug therapy/therapy KW - Pandemics KW - Patient Satisfaction KW - SARS-CoV-2 KW - Telemedicine/organization & administration KW - healthcare delivery KW - opioid use KW - Pandemic AU - K. Alexander AU - M. Pogorzelska-Maziarz AU - A. Gerolamo AU - N. Hassen AU - E. L. Kelly AU - K. L. Rising A1 - AD - Jefferson College of Nursing, Thomas Jefferson University, 901 Walnut St., Suite 800, Philadelphia, PA, 19107, USA. Karen.Alexander@jefferson.edu.; Jefferson College of Nursing, Thomas Jefferson University, 901 Walnut St., Suite 800, Philadelphia, PA, 19107, USA.; Jefferson College of Nursing, Thomas Jefferson University, 901 Walnut St., Suite 800, Philadelphia, PA, 19107, USA.; Jefferson College of Nursing, Thomas Jefferson University, 901 Walnut St., Suite 800, Philadelphia, PA, 19107, USA.; Department of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, 1015 Walnut Street, Suite 40, Philadelphia, PA, 19107, USA.; Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, 1020 Sansom Street, Suite 239, Philadelphia, PA, 19107, USA. BT - Substance abuse treatment, prevention, and policy C5 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use CP - 1 DO - 10.1186/s13011-021-00395-6 IS - 1 JF - Substance abuse treatment, prevention, and policy LA - eng M1 - Journal Article PB - . The Author(s) PY - 2021 SN - 1747-597X; 1747-597X SP - 60 T1 - The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review T2 - Substance abuse treatment, prevention, and policy TI - The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review U1 - Education & Workforce; Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use U2 - 34372900 U3 - 10.1186/s13011-021-00395-6 VL - 16 VO - 1747-597X; 1747-597X Y1 - 2021 Y2 - Aug 9 ER -